James E. Robinson

James E. Robinson, H. Jaspan, R. Garry, 2004, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Shaping T Cell – B Cell Collaboration in the Response to Human Immunodeficiency Virus Type 1 Envelope Glycoprotein gp120 by Peptide Priming

N. K. Steede, James E. Robinson, S. Landry, 2013, PloS one.

Neutralization Resistance of Virological Synapse-Mediated HIV-1 Infection Is Regulated by the gp41 Cytoplasmic Tail

James E. Robinson, Rebecca Lee, Benjamin K. Chen, 2012, Journal of Virology.

Characterization of Structural Features and Diversity of Variable-Region Determinants of Related Quaternary Epitopes Recognized by Human and Rhesus Macaque Monoclonal Antibodies Possessing Unusually Potent Neutralizing Activities

S. Zolla-Pazner, M. Gorny, James E. Robinson, 2011, Journal of Virology.

Identification of Novel Structural Determinants in MW965 Env That Regulate the Neutralization Phenotype and Conformational Masking Potential of Primary HIV-1 Isolates

James E. Robinson, A. Pinter, W. Honnen, 2017, Journal of Virology.

Seroprevalence of simian immunodeficiency virus in wild and captive born Sykes' monkeys (Cercopithecus mitis) in Kenya

James E. Robinson, S. Michael, B. Ellis, 2004, Retrovirology.

Diverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 binding

M. Sajadi, James E. Robinson, M. Pazgier, 2012, Proceedings of the National Academy of Sciences.

Quaternary Epitope Specificities of Anti-HIV-1 Neutralizing Antibodies Generated in Rhesus Macaques Infected by the Simian/Human Immunodeficiency Virus SHIVSF162P4

L. Stamatatos, S. Zolla-Pazner, M. Gorny, 2010, Journal of Virology.

a Mouse Model of HIV Infection Not Anti-Glycoprotein 120 , Immunotoxins in In Vivo Efficacy of Anti-Glycoprotein 41

James E. Robinson, S. Pincus, W. Olson, 2003 .

In Vivo Efficacy of Anti-Glycoprotein 41, But Not Anti-Glycoprotein 120, Immunotoxins in a Mouse Model of HIV Infection 1

James E. Robinson, S. Pincus, W. Olson, 2003, The Journal of Immunology.

Structural analysis of human and macaque mAbs 2909 and 2.5B: implications for the configuration of the quaternary neutralizing epitope of HIV-1 gp120.

S. Zolla-Pazner, M. Gorny, M. Totrov, 2011, Structure.

Edinburgh Research Explorer Variation in HIV-I R5 macrophage-tropism correlates with sensitivity to reagents that block envelope: CD4 interactions but not with sensitivity to other entry inhibitors

D. Burton, P. Simmonds, J. Ball, 2022 .

Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever

Donald S. Grant, James E. Robinson, R. Garry, 2017, Nature Medicine.

Treatment of Lassa virus infection in outbred guinea pigs with first-in-class human monoclonal antibodies.

Donald S. Grant, James E. Robinson, R. Garry, 2016, Antiviral research.

A Conserved Determinant in the V1 Loop of HIV-1 Modulates the V3 Loop To Prime Low CD4 Use and Macrophage Infection

S. Zolla-Pazner, J. Ball, James E. Robinson, 2010, Journal of Virology.

Delineating the mechanism of anti-Lassa virus GPC-A neutralizing antibodies

E. Saphire, James E. Robinson, R. Garry, 2022, Cell reports.

A New Humanized Mouse Model Mimics Humans in Lacking α-Gal Epitopes and Secreting Anti-Gal Antibodies

C. Bollensdorff, W. Marasco, James E. Robinson, 2020, The Journal of Immunology.

An inducible HIV type 1 gp41 HR-2 peptide-binding site on HIV type 1 envelope gp120.

H. Liao, B. Haynes, S. Alam, 2004, AIDS research and human retroviruses.

Highly conserved β16/β17 β-hairpin structure in human immunodeficiency virus type 1 YU2 gp120 is critical for CCR5 binding

D. Missé, F. Roquet, James E. Robinson, 2005, Journal of Molecular Medicine.

Identification of Human Anti-HIV gp160 Monoclonal Antibodies That Make Effective Immunotoxins

D. Hamer, D. Dimitrov, James E. Robinson, 2016, Journal of Virology.

Interaction with Cellular CD4 Exposes HIV-1 Envelope Epitopes Targeted by Antibody-Dependent Cell-Mediated Cytotoxicity

J. Sodroski, B. Haynes, D. Kaufmann, 2013, Journal of Virology.

HIV type 1 Env precursor cleavage state affects recognition by both neutralizing and nonneutralizing gp41 antibodies.

J. Mascola, R. Wyatt, K. Mckee, 2011, AIDS research and human retroviruses.

Identification and Targeting of Thomsen–Friedenreich and IL1RAP Antigens on Chronic Myeloid Leukemia Stem Cells Using Bi-Specific Antibodies

James E. Robinson, S. Braun, E. Alt, 2021, OncoTargets and therapy.

Crystal Structure of Human Antibody 2909 Reveals Conserved Features of Quaternary Structure-Speciﬁc Antibodies That Potently Neutralize HIV-1 (cid:1) †§

J. Mascola, L. Stamatatos, S. Zolla-Pazner, 2011 .

Characterization ofConserved HumanImmunodeficiency VirusType1 gpl20Neutralization Epitopes Exposed upon gpl20-CD4 Binding

J. Sodroski, James E. Robinson, C. Furman, 1993 .

Characterization of Antibodies That Inhibit HIV gp120 Antigen Processing and Presentation

M. Gorny, James E. Robinson, Yuxian He, 2005, Retrovirology.

Inﬂuence of Disulﬁde-Stabilized Structure on the Speciﬁcity of Helper T-Cell and Antibody Responses to HIV Envelope Glycoprotein gp120 (cid:1)

N. K. Steede, James E. Robinson, S. Landry, 2010 .

A Highly Conserved Residue of the HIV-1 gp120 Inner Domain Is Important for Antibody-Dependent Cellular Cytotoxicity Responses Mediated by Anti-cluster A Antibodies

F. Kirchhoff, P. Bjorkman, B. Hahn, 2015, Journal of Virology.

CD4-Induced Conformational Changes in the Human Immunodeficiency Virus Type 1 gp120 Glycoprotein: Consequences for Virus Entry and Neutralization

J. Sodroski, Q. Sattentau, J. Gershoni, 1998, Journal of Virology.

Design and In Vivo Characterization of Immunoconjugates Targeting HIV gp160

D. Hamer, James E. Robinson, S. Pincus, 2016, Journal of Virology.

Antiviral Resistance and Correlates of Virologic Failure in the first Cohort of HIV-Infected Children Gaining Access to Structured Antiretroviral Therapy in Lima, Peru: A Cross-Sectional Analysis

James E. Robinson, Max von Kleist, B. Rath, 2013, BMC Infectious Diseases.

Access of Antibody Molecules to the Conserved Coreceptor Binding Site on Glycoprotein gp120 Is Sterically Restricted on Primary Human Immunodeficiency Virus Type 1

Christoph Grundner, Christos J. Petropoulos, Terri Wrin, 2003, Journal of Virology.

Functional Mimicry of a Human Immunodeficiency Virus Type 1 Coreceptor by a Neutralizing Monoclonal Antibody

E. Rosenberg, J. Sodroski, S. Xiang, 2005, Journal of Virology.

Live Simian Immunodeficiency Virus Vaccine Correlate of Protection: Local Antibody Production and Concentration on the Path of Virus Entry

D. Burton, S. Pambuccian, J. Carlis, 2014, The Journal of Immunology.

Broad and Potent Neutralizing Antibody Responses Elicited in Natural HIV-2 Infection

G. Gottlieb, N. Kiviat, G. Shaw, 2011, Journal of Virology.

Comprehensive Analysis of Contributions from Protein Conformational Stability and Major Histocompatibility Complex Class II-Peptide Binding Affinity to CD4+ Epitope Immunogenicity in HIV-1 Envelope Glycoprotein

Ramgopal R. Mettu, N. K. Steede, James E. Robinson, 2014, Journal of Virology.

Studies on GM-CSF DNA as an adjuvant for neutralizing Ab elicited by a DNA/MVA immunodeficiency virus vaccine.

P. Earl, B. Moss, D. Montefiori, 2006, Virology.

A model for the maturation of protective antibody responses to SIV envelope proteins in experimentally immunized monkeys

J. Clements, James E. Robinson, R. Montelaro, 1997, Journal of medical primatology.

Access of antibody molecules to th conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary HIV-1

J. Sodroski, J. Binley, R. Wyatt, 2009 .

An Outbreak of Ebola Virus Disease in the Lassa Fever Zone.

Jing He, David Kargbo, Erica Ollmann Saphire, 2016, The Journal of infectious diseases.

Current and emerging strategies for the diagnosis, prevention and treatment of Lassa fever

Donald S. Grant, L. Moses, James E. Robinson, 2015 .

Lassa Fever in Post-Conflict Sierra Leone

Pardis C Sabeti, Donald S. Grant, L. Moses, 2014, PLoS neglected tropical diseases.

Lassa hemorrhagic fever in a late term pregnancy from northern sierra leone with a positive maternal outcome: case report

Pardis C Sabeti, Donald S. Grant, L. Moses, 2011, Virology Journal.

Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits

Pardis C Sabeti, Donald S. Grant, Mohamed A. Vandi, 2016, Nature Communications.

Structural basis for antibody-mediated neutralization of Lassa virus

K. Chandran, E. Saphire, James E. Robinson, 2017, Science.

Convergent Structures Illuminate Features for Germline Antibody Binding and Pan-Lassa Virus Neutralization

E. Saphire, James E. Robinson, A. Koval, 2019, Cell.

Detection of HIV gp120 in plasma during early HIV infection is associated with increased proinflammatory and immunoregulatory cytokines.

E. Rosenberg, James E. Robinson, J. Rychert, 2010, AIDS research and human retroviruses.

Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient

James E. Robinson, S. Michael, S. Isern, 2010, Virology Journal.

Potent Autologous and Heterologous Neutralizing Antibody Responses Occur in HIV-2 Infection across a Broad Range of Infection Outcomes

S. Rowland-Jones, H. Whittle, R. Weiss, 2011, Journal of Virology.

Heterogeneity in Neutralization Sensitivities of Viruses Comprising the Simian Immunodeficiency Virus SIVsmE660 Isolate and Vaccine Challenge Stock

G. Learn, G. Shaw, B. Hahn, 2013, Journal of Virology.

Mechanistic Study of Broadly Neutralizing Human Monoclonal Antibodies against Dengue Virus That Target the Fusion Loop

James E. Robinson, L. Chernomordik, S. Michael, 2012, Journal of Virology.

Structure and Recognition of a Novel HIV-1 gp120-gp41 Interface Antibody that Caused MPER Exposure through Viral Escape

J. Mascola, D. Burton, M. Connors, 2017, PLoS pathogens.

HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites

Peter D. Kwong, Wayne A. Hendrickson, Michael L. Doyle, 2002, Nature.

Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site

Daniel W. Kulp, J. Mascola, J. Binley, 2015, PLoS pathogens.

The B Cell Response Is Redundant and Highly Focused on V1V2 during Early Subtype C Infection in a Zambian Seroconverter

A. Sethi, S. Gnanakaran, J. Mulenga, 2010, Journal of Virology.

Neutralizing activity of antibodies to the V3 loop region of HIV-1 gp120 relative to their epitope fine specificity.

D. Burton, T. Wrin, L. Cavacini, 2008, Virology.

Human Immunodeficiency Virus Type 1 gp41 Antibodies That Mask Membrane Proximal Region Epitopes: Antibody Binding Kinetics, Induction, and Potential for Regulation in Acute Infection

S. Munir Alam, Susan Zolla-Pazner, Barton F. Haynes, 2007, Journal of Virology.

Assorted Mutations in the Envelope Gene of Simian Immunodeficiency Virus Lead to Loss of Neutralization Resistance against Antibodies Representing a Broad Spectrum of Specificities

D. Burton, P. Parren, R. Desrosiers, 2003, Journal of Virology.

Comparison of Antibody-Dependent Cell-Mediated Cytotoxicity and Virus Neutralization by HIV-1 Env-Specific Monoclonal Antibodies

S. Zolla-Pazner, D. Burton, James E. Robinson, 2016, Journal of Virology.

An HIV-1 gp120 Envelope Human Monoclonal Antibody That Recognizes a C1 Conformational Epitope Mediates Potent Antibody-Dependent Cellular Cytotoxicity (ADCC) Activity and Defines a Common ADCC Epitope in Human HIV-1 Serum

J. Kappes, B. Haynes, J. Hoxie, 2011, Journal of Virology.

Conformational Epitope Mediates Potent ADCC Activity and Defines a Common 2

J. Kappes, B. Haynes, J. Hoxie, 2011 .

Structural Definition of an Antibody-Dependent Cellular Cytotoxicity Response Implicated in Reduced Risk for HIV-1 Infection

J. Foulke, M. Sajadi, P. Acharya, 2014, Journal of Virology.

Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120.

Wayne A Hendrickson, Peter D Kwong, Joseph Sodroski, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Cocrystal Structures of Antibody N60-i3 and Antibody JR4 in Complex with gp120 Define More Cluster A Epitopes Involved in Effective Antibody-Dependent Effector Function against HIV-1

M. Sajadi, P. Acharya, P. Kwong, 2015, Journal of Virology.

Use of tissue culture cell lines to evaluate HIV antiviral resistance.

S. Broyles, James E. Robinson, S. Pincus, 2008, AIDS research and human retroviruses.

Highly conserved beta16/beta17 beta-hairpin structure in human immunodeficiency virus type 1 YU2 gp120 is critical for CCR5 binding.

D. Missé, F. Roquet, James E. Robinson, 2005, Journal of molecular medicine.

Characterization and Implementation of a Diverse Simian Immunodeficiency Virus SIVsm Envelope Panel in the Assessment of Neutralizing Antibody Breadth Elicited in Rhesus Macaques by Multimodal Vaccines Expressing the SIVmac239 Envelope

B. Pulendran, J. Robinson, E. Hunter, 2015, Journal of Virology.

Epitope mapping and characterization of a novel CD4-induced human monoclonal antibody capable of neutralizing primary HIV-1 strains.

Peter D Kwong, Joseph Sodroski, E. Rosenberg, 2003, Virology.

Characterization of CD4-induced epitopes on the HIV type 1 gp120 envelope glycoprotein recognized by neutralizing human monoclonal antibodies.

Joseph Sodroski, J. Sodroski, S. Xiang, 2002, AIDS research and human retroviruses.

UvA-DARE ( Digital Academic Repository ) Neutralizing antibodies to the HIV-1 envelope glycoproteins

C. Broder, J. Binley, D. Burton, 2009 .

Probability Analysis of Variational Crystallization and Its Application to gp120, The Exterior Envelope Glycoprotein of Type 1 Human Immunodeficiency Virus (HIV-1)*

J. Sodroski, R. Wyatt, J. Culp, 1999, The Journal of Biological Chemistry.

Epitopes for broad and potent neutralizing antibody responses during chronic infection with human immunodeficiency virus type 1.

David C Montefiori, Georgia D Tomaras, Avishek Nandi, 2010, Virology.

Reproducing SIV&Dgr;nef vaccine correlates of protection: trimeric gp41 antibody concentrated at mucosal front lines

D. Burton, A. Haase, R. Johnson, 2016, AIDS.

Conformational instability governed by disulfide bonds partitions the dominant from subdominant helper T-cell responses specific for HIV-1 envelope glycoprotein gp120.

N. K. Steede, James E. Robinson, Hong-Nam Nguyen, 2015, Vaccine.

Multi-parameter exploration of HIV-1 virus-like particles as neutralizing antibody immunogens in guinea pigs, rabbits and macaques.

J. Binley, C. Apetrei, E. Crooks, 2014, Virology.

Multi-Parameter Exploration of HIV-1 Virus-Like Particles as Neutralizing Antibody Immunogens in Guinea Pigs, Rabbits and Macaques.

J. Binley, C. Apetrei, E. Crooks, 2014, Virology.

CD4-Mimetic Small Molecules Sensitize Human Immunodeficiency Virus to Vaccine-Elicited Antibodies

H. Liao, J. Sodroski, B. Haynes, 2014, Journal of Virology.

High frequencies of antibody responses to CD4 induced epitopes in HIV infected patients started on HAART during acute infection.

E. Rosenberg, James E. Robinson, D. Elliott, 2006, Human antibodies.

The N-Terminal V3 Loop Glycan Modulates the Interaction of Clade A and B Human Immunodeficiency Virus Type 1 Envelopes with CD4 and Chemokine Receptors

David Yang, C. Cheng‐Mayer, L. Cavacini, 2000, Journal of Virology.

Neutralization and infectivity characteristics of envelope glycoproteins from human immunodeficiency virus type 1 infected donors whose sera exhibit broadly cross-reactive neutralizing activity.

H. Katinger, James E. Robinson, L. Heyndrickx, 2006, Virology.

Topological Analysis of HIV-1 Glycoproteins Expressed In Situ on Virus Surfaces Reveals Tighter Packing but Greater Conformational Flexibility than for Soluble gp120

T. Tong, K. Osawa, J. E. Robinson, 2013, Journal of Virology.

Interactions of human antibodies, epitope exposure, antibody binding and neutralization of primary isolate HIV-1 virions

L. Cavacini, James E. Robinson, M. Posner, 2002, AIDS.

Specific sequences commonly found in the V3 domain of HIV-1 subtype C isolates affect the overall conformation of native Env and induce a neutralization-resistant phenotype independent of V1/V2 masking.

S. Zolla-Pazner, M. Gorny, James E. Robinson, 2014, Virology.

Influence of Disulfide-Stabilized Structure on the Specificity of Helper T-Cell and Antibody Responses to HIV Envelope Glycoprotein gp120

N. K. Steede, James E. Robinson, S. Landry, 2010, Journal of Virology.

Molecular Effects of Volume Expansion on the Renal Sodium Phosphate Cotransporter

P. Deininger, James E. Robinson, J. Puschett, 2003, The American journal of the medical sciences.

Characterization of CD 4-Induced Epitopes on the HIV Type 1 gp 120 Envelope Glycoprotein Recognized by Neutralizing Human Monoclonal Antibodies

J. Sodroski, S. Xiang, James E. Robinson, 2013 .

Relationship of HIV-1 and SIV envelope glycoprotein trimer occupation and neutralization.

J. Hoxie, J. Binley, P. Moore, 2008, Virology.

Immunogenicity of Constrained Monoclonal Antibody A32-Human Immunodeficiency Virus (HIV) Env gp120 Complexes Compared to That of Recombinant HIV Type 1 gp120 Envelope Glycoproteins

John R. Mascola, S. Munir Alam, Barton F. Haynes, 2004, Journal of Virology.

Live Simian Immunodeficiency Virus Vaccine Correlate of Protection: Immune Complex–Inhibitory Fc Receptor Interactions That Reduce Target Cell Availability

J. Carlis, A. Haase, C. Reilly, 2014, The Journal of Immunology.

Live SIV vaccine correlate of protection : immune complex-inhibitory Fc receptor interactions that reduce target cell availability

J. Carlis, A. Haase, C. Reilly, 2016 .

Discontinuous, conserved neutralization epitopes overlapping the CD4-binding region of human immunodeficiency virus type 1 gp120 envelope glycoprotein

J. Sodroski, D. Ho, J. Robinson, 1992, Journal of virology.

Neutralizing antibodies to the HIV-1 envelope glycoproteins

C. Broder, J. Binley, D. Burton, 2004 .

Variation in HIV-1 R5 macrophage-tropism correlates with sensitivity to reagents that block envelope: CD4 interactions but not with sensitivity to other entry inhibitors

P. Simmonds, J. Ball, J. Bell, 2008, Retrovirology.